Epidemiological trends and clinical relevance of nontuberculous mycobacterial pulmonary disease in a referral hospital in Japan, 2017-2021

被引:0
|
作者
Ito, Masashi [1 ,2 ]
Furuuchi, Koji [1 ]
Fujiwara, Keiji [1 ,3 ]
Kodama, Tatsuya [1 ,3 ]
Tanaka, Yoshiaki [1 ]
Yoshiyama, Takashi [1 ]
Ogata, Hideo [1 ]
Kurashima, Atsuyuki [1 ]
Ohta, Ken [1 ]
Morimoto, Kozo [1 ,2 ,4 ]
机构
[1] Japan AntiTB Assoc, Fukujuji Hosp, Resp Dis Ctr, 3-1-24 Matsuyama, Kiyose, Tokyo 2048522, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Mycobacteriosis, Nagasaki 8528523, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Dept Basic Mycobacteriosis, Nagasaki 8528523, Japan
[4] Japan AntiTB Assoc, Div Clin Res, Fukujuji Hosp, Tokyo 2048522, Japan
关键词
Nontuberculous mycobacteria; Mycobacterium avium complex; Mycobacterium abscessus; Mycobacterium gordonae; MALDI-TOF MS; FEATURES; DIAGNOSIS; TUBERCULOSIS; CRITERIA;
D O I
10.1016/j.resinv.2024.09.007
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Epidemiological trends and clinical relevance of NTM species in Japan following the adoption of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry remain unclear. Methods: We analyzed the results of mycobacterial culture tests of respiratory specimens collected between January 2017 and December 2021. We assessed the clinical relevance of NTM species by analyzing the proportion of patients diagnosed with NTM pulmonary infection (NTM-PI). We illustrated the incidence and clinical relevance of each NTM species using a two-dimensional scatter plot. Medical chart review and radiological analysis were also performed for less common species. Results: Among 65,368 respiratory specimens tested for acid-fast bacilli, NTM were identified in 12,802 specimens from 3177 patients. The number of incident cases with NTM-PI has continued to increase. Notably, the number of incident cases with M. abscessus species (MABS) was continuously increasing and accounted for 10.6% of all incident cases with NTM-PI. The clinical relevance of the common NTM species, M. avium complex, MABS and M. kansasii, ranged from 57 to 72%. Seven other species exhibited a higher clinical relevance than these common NTM species, with M. shinjukuense (100%) having the highest clinical relevance. On the other hand, 11 species, including M. fortuitum (32.4%), M. xenopi (20.0%), and M. gordonae (22.9%), showed clinical relevance below 50%. Conclusions: The present study clarified the incidence and clinical relevance of NTM species using a two-dimensional scatter plot, which could serve as a useful tool for clinical decision-making and future epidemiological research.
引用
收藏
页码:1064 / 1071
页数:8
相关论文
共 30 条
  • [1] Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan
    Furuuchi, Koji
    Morimoto, Kozo
    Yoshiyama, Takashi
    Tanaka, Yoshiaki
    Fujiwara, Keiji
    Okumura, Masao
    Izumi, Kiyohiko
    Shiraishi, Yuji
    Mitarai, Satoshi
    Ogata, Hideo
    Kurashima, Atsuyuki
    Yoshimori, Kozo
    Ohta, Ken
    Goto, Hajime
    Sasaki, Yuka
    RESPIRATORY MEDICINE, 2019, 152 : 74 - 80
  • [2] Clinical relevance and diagnosis of nontuberculous mycobacterial pulmonary disease in populations at risk
    Feng, Jia-Yih
    Chen, Wei-Chih
    Chen, Ying-Ying
    Su, Wei-Juin
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 : S23 - S31
  • [3] Nontuberculous Mycobacterial Pulmonary Disease: Clinical Epidemiologic Features, Risk Factors, and Diagnosis The Nontuberculous Mycobacterial Series
    Kumar, Kartik
    Loebinger, Michael R.
    CHEST, 2022, 161 (03) : 637 - 646
  • [4] Nontuberculous Mycobacterial Pulmonary Disease: A Clinical and Radiologic Update
    Nguyen, Ivy
    Green, ONeil
    Modahl, Lucy
    SEMINARS IN ROENTGENOLOGY, 2022, 57 (01) : 75 - 89
  • [5] Pathogenic Classification and Clinical Characteristics of Nontuberculous Mycobacterial Pulmonary Disease in a National Tuberculosis Hospital
    Choi, Sun-Pil
    Lee, Bong-Keun
    Min, Jin-Hong
    Kim, Jin-Hee
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2005, 59 (06) : 606 - 612
  • [6] Clinical course of nontuberculous mycobacterial pulmonary disease in patients with rheumatoid arthritis
    Kwak, Nakwon
    Moon, Jinyoung
    Kim, Joong-Yub
    Park, Jun Won
    Yim, Jae-Joon
    ADVANCES IN RHEUMATOLOGY, 2024, 64 (01)
  • [7] Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan
    Izumi, Kiyohiko
    Morimoto, Kozo
    Hasegawa, Naoki
    Uchimura, Kazuhiro
    Kawatsu, Lisa
    Ato, Manabu
    Mitarai, Satoshi
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2019, 16 (03) : 341 - 347
  • [8] Nontuberculous mycobacterial pulmonary disease added burden to COPD and bronchiectasis in Japan
    Wang, Ping
    Morimoto, Kozo
    Hasegawa, Naoki
    Hassan, Mariam
    Chatterjee, Anjan
    ERJ OPEN RESEARCH, 2024, 10 (04)
  • [9] Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline
    Daley, Charles L.
    Iaccarino, Jonathan M.
    Lange, Christoph
    Cambau, Emmanuelle
    Wallace, Richard J., Jr.
    Andrejak, Claire
    Boettger, Erik C.
    Brozek, Jan
    Griffith, David E.
    Guglielmetti, Lorenzo
    Huitt, Gwen A.
    Knight, Shandra L.
    Leitman, Philip
    Marras, Theodore K.
    Olivier, Kenneth N.
    Santin, Miguel
    Stout, Jason E.
    Tortoli, Enrico
    van Ingen, Jakko
    Wagner, Dirk
    Winthrop, Kevin L.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (04) : 905 - 913
  • [10] Clinical characteristics and diagnostic practices in nontuberculous mycobacterial pulmonary disease: Insights from Denmark
    Dahl, Victor Naestholt
    Floe, Andreas
    Rudolf, Frauke
    van Ingen, Jakko
    Andersen, Aase Bengaard
    Wejse, Christian Morberg
    Lillebaek, Troels
    RESPIRATORY MEDICINE, 2025, 241